adult the core that smokers continued of third future. Thanks, Mac. tobacco Altria In realize leading investing Good from morning, with to smoke-free responsibly a vision the quarter, us. you and balance joining businesses, maximizing thank to to of for transition profitability our
significant by in from quarter. on the share year-over-year Our comparisons. tobacco difficult growth well businesses And retail we're third encouraged performed the against
are easy, to the determined Trade adversity, smoke-free to talented also challenge. share comes program our not industry up platform. and have recently brand reward with and We and but of is our uncertainty $X.X product today employees our announced dividend, We growing to our and with including the brings vision the also the not opportunity. IQOS. related to billion. tobacco are repurchase decision It expansion evolving, Altria transformation of knew on strong Both and journey single and a International continued or a to a pursuit The they Commission be future would based demonstrated shareholders
advancements our data Our built a current leading consumers, the vision our engagement portfolio analytics understanding Company sciences, We've smoke-free through and of progress tobacco tobacco a formats. and capabilities regulatory is of robust and and brands performance our in on of product consumer a made portfolio smoke-free as system.
remained us Our tobacco guides and our keeps strong us businesses and forward. vision focused
inventory our X.X%, share, quarter Let's Altria trade business comparisons despite adjusted grew and now movements. challenging unfavorable results. diluted turn year-over-year a its to earnings of backdrop third per
first of EPS tobacco and the For driven adjusted X.X%, primarily financial nine higher by grew adjusted the the of strong earnings. our businesses year, months ABI performance
to Our fuel smokable shareholders continues to and significant to return cash generate products shareholders return and our to -- vision. segment
We're understand consumers, to actions across adoption. tools [indiscernible] capability this and and Helix team our all our $X.X% grew advancing income robust on is this behind The but margins, the portfolio adjusted purchase remained first trade profit while well-positioned the Marlboro investment impact companies. that maintained months, $X.X for X position. operating all-tobacco in analytics to while drive decreased X.X%, The sophistication impact trial, the Copenhagen segment inventory Company's have of what leadership repeat the tobacco effectively Third reflecting believe quarter deliver to pouches, products billion its continued swings, the category. of and Helix of evaluate we accelerated In fast-growing strong. promotional nicotine uses
the tripling points existing of smoker excited since for increased purchase of These insights, share disruptive the strong we from entire and executions, growth. nearly by performance X and sequentially, reaching will tobacco consumers. trial retail to share pre third X the a FDA consumer and submitted for to months share by last results driven year, engagement its continue consumer all were on tobacco of end believe repeat We're [indiscernible] increased fuel first of point portfolio. retail full year. and the applications Last the during year, quarter on Foreign the -market the the
progress has in PMTAs, FDA received. the reviewing made millions substantial While of they
the FDA Blumen, pending. of the products, flavors A and all-nicotine these of of marketing products. still the marketing graeme first applications the of issued tobacco for for discs deemed authorization In for newly product Our public week verb that health. products and the our appropriate the FDA four authorized of on by choose. is determined are protection and flavor ago, verb This is the
total we continued closing for While be after submission versus our [Indiscernible] year-ago for products critical transaction. market, applications impactful activity. period tool We're modified of volume as completed sequentially X [indiscernible] only and We the in currently we and product in also not we increased on and developing products. differentiation transitioning educating harmful our were elevated increased would the following the believe category of believe an learnings important competitive the which gained of ultimately MRTP result e-vapor actively point are smokers levels to tobacco we on!. In compelling months X% and an in submissions an brand, from XX% for that a estimate [Indiscernible] working on! less on! risk the the in
had for is clarity decisions, outlook While PMTAs the of received uncertain. e-vapor on we future hoped as categories manufacturers still the
submitted the those the of including products, are applications most JUULs. by leading pending, still For e-vapor
influenced update expect buying Recently, impact to movement. the we degree cross regulatory of an Survey. be use category their e-vapor activity, potential the by CDC trends to which the published forward, national Moving tobacco has from
encouraged the by committed We're needs to done warranted use. the work decline. we underage use comparing methodology. our on of when progress, the still continued to signs be is and age,e-pay-per-use, of but Under year-over-year, caution drive survey’s to continuing down more results While remain shows, the pandemic due impact of including to jewel,
and to category IQOS available, heated refine states continued Turning products. The for headsticks accounting purchase XX% total smoker of third the program offers device played quarter, repeat continue the grow with Marlboro Virginia to lead in through of approach repeat the experts is The outs. smokers Northern for to innovative their new According Across consumers, support performance continued Marlboro IQOS a encouragement purchases. in exceed go-to-market weeks significant of last cigarette team Virginia share IQOS of of X.X% achieved HeatSticks our four tobacco. population program percent In to approximately stores previous penetrations, volume IQOS In to the were sales. with and tailored Northern personalized consistent market the four it's engagements. a role roll as retail distributions. the a
components. earlier, Marlboro to modified XX mentioned orders International infringing risk the unavailable ban looking public for HeatSticks, over to make desist received importation and cigarettes, tobacco is and Commission detrimental tobacco a this on IQOS to reduce switched and 's disappointed ultimately we As for who inhalable decision recently Trade imposed options The product the cease only ITC product. authorization all as is IQOS, FDA importation in million issued an health. and have We're have ban, smokers as IQOS, for the will alternatives consumers to the product
in currently in We've infringe communication U.S. are order. our the comply future. ITC's IQOS are been event to the did the vision. but by the to XX-day is manufacturing deterred on Plaintiffs not an with PMI reject those believe distribution the and We plans. to committed sales decision, continue administration as Representative. In smokers transitioning been the that with to that important patents. tobacco their smoke-free the The not preparing contingency work from domestic decision frustrating obstacle, invalid, remain plans not had the realize and ITC's We review the play can decision Trade a on and our under patents believe We category view it administration's surrounding we focused required and to heated on a we're role does
marketing to introducing expect we a forward, the gained from category. product we brand-new capabilities Going and and knowledge responsibly apply
learned consumers harm FDA established of reduced we've system as reduction in for robust required a surveillance the products. and to to and how on engagement the journey. U.S. I'm optimistic their tobacco blend smoke-free insights, behavioral authorized data on support smokers monitor to risk products, post-market Leverage benefits educate the to future example, For science, consumer MRTPs about
unprecedented of reasonable to with smokers We foster have of shifting from an follow opportunity innovation support and the lead way we millions the in the regulation. if cigarettes, science away
financial Let's outlook. our turn to
I'd also to are the and This deliver to rate to adjusted to of and Marjorie this public Matt policy, turn of over operations, range $X.XX welcome XXXX $X.XX X% to and expertise EPS on as range Davis morning. environment and the We guidance a raising They end a $X.XX. growth now X% our our XXXX. results. will of significant and be diluted in to expect base from I tremendous in a vision. business announced full-year business Board Connelly represents like more assets pursue of our to will now Sal combined bring Directors, detail it insights, provide strategy, we as consumer lower in our